Clinical Trial Results

Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

PHASE4INTERVENTIONAL New Haven, Connecticut +4 more

RECRUITING

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

PHASE3INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

PHASE1INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

N/AOBSERVATIONAL Birmingham, Alabama +4 more

RECRUITING

Confirmatory Trial for Alleviating Fatigue in Multiple Sclerosis

NAINTERVENTIONAL Washington D.C., District of Columbia +4 more

RECRUITING

An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

PHASE1INTERVENTIONAL Tucson, Arizona +4 more

RECRUITING

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more

RECRUITING

Genes and Environment in Multiple Sclerosis

N/AOBSERVATIONAL Bethesda, Maryland +4 more

RECRUITING

Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

Pathological Basis of MRI Signal Changes in Multiple Sclerosis

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

PHASE2INTERVENTIONAL Bethesda, Maryland

RECRUITING

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

PHASE1, PHASE2INTERVENTIONAL Bethesda, Maryland

RECRUITING

A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

N/AOBSERVATIONAL Bethesda, Maryland +2 more

RECRUITING

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

PHASE1INTERVENTIONAL Bethesda, Maryland

RECRUITING

Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System

N/AOBSERVATIONAL Bethesda, Maryland

RECRUITING

RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses

PHASE2INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis

PHASE1INTERVENTIONAL Carlsbad, California +4 more

RECRUITING

Solriamfetol for the Treatment of Multiple Sclerosis Fatigue

PHASE2INTERVENTIONAL Baltimore, Maryland

RECRUITING

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

NAINTERVENTIONAL Irvine, California +4 more

RECRUITING

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

NAINTERVENTIONAL Baltimore, Maryland

RECRUITING

Study of Ublituximab for Ocrelizumab Wearing-Off in Multiple Sclerosis

PHASE4INTERVENTIONAL Baltimore, Maryland

RECRUITING

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

PHASE2INTERVENTIONAL Baltimore, Maryland +1 more

RECRUITING